Reaction profile

The FDA adverse-event record for low parathyroid (pth) concentration

11 FDA reports name low parathyroid (pth) concentration, a lower-volume reaction in the CVM extract (VeDDRA 2665). Plate stamps and neighbourhood peers follow.

#2432 of 2,481
by report volume (all reactions)
11
reports citing this reaction
9.1%
death-coded share
Cat
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Low parathyroid (PTH) concentration has 11 reports now versus 11 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Low parathyroid (PTH) concentration changes

FDA AER · VeDDRA plate

Code 2665 VOL-TRACE

VOL-TRACE · DEATH-PAR · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-MID · BOOK-FULL

  • VOL-TRACE 11 reports
  • DEATH-PAR 9.1%
  • BOTTOM-DECILE #2432/2481
  • PHOTO-FINISH ABNORMAL PANCREATIC S…
  • SPECIES-CAT Cat · 8
  • DRUG-LEAD Bexagliflozin · 4
  • DESK-MID 7 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: ABNORMAL PANCREATIC SPECIFIC LIPASE (PLI) (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Low parathyroid concentration

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348ABNORMAL PANCREATIC S… · near11Aortic stenosis · near11Aqueous flare · near11Bile duct inflammation · near11Low parathyroid (PTH)… · thi…11Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Low parathyroid (PTH) concentration

What the FDA AER plate says about Low parathyroid (PTH) concentration

Signature read: 11 reports place Low parathyroid (PTH) concentration in the lower third of FDA AER volume (#2432 of 2,481). Report volume is lower-third scale: 11 named reports in the openFDA extract. 1 of 11 reports were death-coded (9.1% of named reports, not a population mortality rate). Nearest volume peer: ABNORMAL PANCREATIC SPECIFIC LIPASE (PLI) (±0 reports). Lead species Cat (8). Lead co-reported drug Bexagliflozin (4).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Bexagliflozin appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 8
Dog 3

Breeds Most Affected

Domestic Shorthair 5
Retriever - Golden 1
Retriever - Flat-coated 1
Shih Tzu 1
American Curl Shorthair 1
American Shorthair 1
Cat (unknown) 1

Associated Drugs

Bexagliflozin 4
Ente Ointment 2
Doxycycline 2
Velagliflozin Proline Monohydrate 2
Robenacoxib 1
Buprenorphine 1
Fluid Therapy (Unknown) 1
Afoxolaner 1
Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride 1
Melarsomine Dihydrochloride 1
Frunevetmab 1
Senvelgo Velagliflozin Oral Solution 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Low parathyroid (PTH) concentration (#2432 of 2,481 by report volume); death-coded 9.1%. PlainBreed reaction plate · report volume stamp 11 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →